Anticholinergic Agents Short-Acting (Inhaled)

Short-acting inhaled anticholinergic agents, also referred to as short-acting muscarinic antagonists (SAMAs), are a therapeutic class of bronchodilators administered by inhalation to relieve acute airflow obstruction They function by competitively antagonizing muscarinic acetylcholine receptors on bronchial smooth muscle, preventing acetylcholine-mediated vagal bronchoconstriction and excessive mucus secretion Clinically typified by ipratropium bromide, these agents provide rapid-onset airway re...

Short-acting inhaled anticholinergic agents, also referred to as short-acting muscarinic antagonists (SAMAs), are a therapeutic class of bronchodilators administered by inhalation to relieve acute airflow obstruction

Short-acting inhaled anticholinergic agents, also referred to as short-acting muscarinic antagonists (SAMAs), are a therapeutic class of bronchodilators administered by inhalation to relieve acute airflow obstruction Clinically typified by ipratropium bromide, these agents provide rapid-onset airway relaxation and are primarily utilized for the maintenance and acute management of chronic obstructive pulmonary disease (COPD) as well as adjunctive therapy in moderate-to-severe acute asthma exacerb...

They function by competitively antagonizing muscarinic acetylcholine receptors on bronchial smooth muscle, preventing acetylcholine-mediated vagal bronchoconstriction and excessive mucus secretion Clinically typified by ipratropium bromide, these agents provide rapid-onset airway relaxation and are primarily utilized for the maintenance and acute management of chronic obstructive pulmonary disease (COPD) as well as adjunctive therapy in moderate-to-severe acute asthma exacerbations

They function by competitively antagonizing muscarinic acetylcholine receptors on bronchial smooth muscle, preventing acetylcholine-mediated vagal bronchoconstriction and excessive mucus secretion

Clinically typified by ipratropium bromide, these agents provide rapid-onset airway relaxation and are primarily utilized for the maintenance and acute management of chronic obstructive pulmonary disease (COPD) as well as adjunctive therapy in moderate-to-severe acute asthma exacerbations